ESC 365 - First clinical evaluation of subcutaneous implantable cardiac defibrillator in Brugada patients

ESC Premium Access

First clinical evaluation of subcutaneous implantable cardiac defibrillator in Brugada patients

Session: News on the ICD front, the transveneous, the subcutaneous and the wearable

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Professor V. Probst (Nantes, FR)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Vincent Probst

University Hospital of Nantes, Nantes (France)

8 presentations

0 follower

5 more presentations in this session

Sudden cardiac death in non-ischemic systolic heart failure : do we only need LVEF to decide ICD implantation ?

Speaker: Doctor T. Mercier (Valenciennes, FR)

Utility of cardiovascular implantable electronic device (CIED)-derived patient activity, a novel digital biomarker, to predict inappropriate therapy

Speaker: Associate Professor V. Kutyifa (Rochester, US)

Risk of life-threatening ventricular tachyarrhythmia events in diabetes patients with higher ejection fraction in MADIT-CRT

Speaker: Professor I. Goldenberg (Rochester, US)

Incidence and predictors of alarms in patients with wearable cardioverter defibrillator (WCD) - results of the Austrian WCD Registry

Speaker: Doctor U. Rohrer (Graz, AT)

Inadequate heart rate control begets sustained ventricular arrhythmias in a large cohort of women

Speaker: Doctor J. Erath (Frankfurt, DE)

Access the full session

News on the ICD front, the transveneous, the subcutaneous and the wearable

Speakers: Professor V. Probst, Doctor T. Mercier, Associate Professor V. Kutyifa, Professor I. Goldenberg, Doctor U. Rohrer...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources